
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8257835
[patent_doc_number] => 08207315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Gene and protein associated with angiogenesis and endothelial cell-specific apoptosis'
[patent_app_type] => utility
[patent_app_number] => 10/569744
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 26450
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10569744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569744 | Gene and protein associated with angiogenesis and endothelial cell-specific apoptosis | Aug 19, 2004 | Issued |
Array
(
[id] => 5056863
[patent_doc_number] => 20070059785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Biomarkers in cancer'
[patent_app_type] => utility
[patent_app_number] => 10/568251
[patent_app_country] => US
[patent_app_date] => 2004-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13425
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059785.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568251 | Biomarkers in cancer | Aug 9, 2004 | Abandoned |
Array
(
[id] => 5880904
[patent_doc_number] => 20060029987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Diagnosis of pancreatic cancer by using pancreatic targets'
[patent_app_type] => utility
[patent_app_number] => 10/912580
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21348
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029987.pdf
[firstpage_image] =>[orig_patent_app_number] => 10912580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/912580 | Diagnosis of pancreatic cancer by using pancreatic targets | Aug 5, 2004 | Abandoned |
Array
(
[id] => 5880905
[patent_doc_number] => 20060029988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Method and compositions for treating diseases targeting E-cadherin'
[patent_app_type] => utility
[patent_app_number] => 10/912582
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 29893
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10912582
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/912582 | Method and compositions for treating diseases targeting E-cadherin | Aug 5, 2004 | Abandoned |
Array
(
[id] => 439130
[patent_doc_number] => 07258983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-21
[patent_title] => 'Cardiotrophin-1 compositions and methods for the treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 10/895545
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32068
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/258/07258983.pdf
[firstpage_image] =>[orig_patent_app_number] => 10895545
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/895545 | Cardiotrophin-1 compositions and methods for the treatment of tumor | Jul 20, 2004 | Issued |
Array
(
[id] => 5106932
[patent_doc_number] => 20070065810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Diagnosis and treatment of cervical cancer'
[patent_app_type] => utility
[patent_app_number] => 10/565021
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11489
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 50
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065810.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565021 | Diagnosis and treatment of cervical cancer | Jul 15, 2004 | Abandoned |
Array
(
[id] => 5642636
[patent_doc_number] => 20060281091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Genes regulated in ovarian cancer a s prognostic and therapeutic targets'
[patent_app_type] => utility
[patent_app_number] => 10/562406
[patent_app_country] => US
[patent_app_date] => 2004-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 32079
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281091.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562406
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562406 | Genes regulated in ovarian cancer a s prognostic and therapeutic targets | Jun 30, 2004 | Abandoned |
Array
(
[id] => 7195794
[patent_doc_number] => 20050164223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Specific method of prostate cancer detection based on PCA3 gene and kits therefor'
[patent_app_type] => utility
[patent_app_number] => 10/880425
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12260
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164223.pdf
[firstpage_image] =>[orig_patent_app_number] => 10880425
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/880425 | Specific method of prostate cancer detection based on PCA3 gene and kits therefor | Jun 29, 2004 | Abandoned |
Array
(
[id] => 5613893
[patent_doc_number] => 20060115821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Prostate specific genes and the use thereof as targets for prostate cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 10/560723
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26175
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560723 | Prostate specific genes and the use thereof as targets for prostate cancer therapy | Jun 24, 2004 | Issued |
Array
(
[id] => 7328323
[patent_doc_number] => 20040253629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Mammalian pro-apoptotic bok genes and their uses'
[patent_app_type] => new
[patent_app_number] => 10/870197
[patent_app_country] => US
[patent_app_date] => 2004-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15734
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10870197
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/870197 | Mammalian pro-apoptotic bok genes and their uses | Jun 15, 2004 | Abandoned |
Array
(
[id] => 6991609
[patent_doc_number] => 20050090646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Gene delivery to tumors'
[patent_app_type] => utility
[patent_app_number] => 10/864774
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 30187
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10864774
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/864774 | Gene delivery to tumors | Jun 8, 2004 | Issued |
Array
(
[id] => 5153912
[patent_doc_number] => 20070036795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist'
[patent_app_type] => utility
[patent_app_number] => 10/560209
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8040
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20070036795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560209
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560209 | Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist | Jun 8, 2004 | Abandoned |
Array
(
[id] => 7169610
[patent_doc_number] => 20050202454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Novel serpentine transmembrane antigens expressed in human cancers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/858887
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20789
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202454.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858887
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858887 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | May 31, 2004 | Issued |
Array
(
[id] => 6958411
[patent_doc_number] => 20050214781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins'
[patent_app_type] => utility
[patent_app_number] => 10/858412
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 195447
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214781.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858412
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858412 | Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins | May 31, 2004 | Abandoned |
Array
(
[id] => 5100707
[patent_doc_number] => 20070183969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers'
[patent_app_type] => utility
[patent_app_number] => 10/558543
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 40487
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20070183969.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558543 | Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers | May 31, 2004 | Issued |
Array
(
[id] => 923034
[patent_doc_number] => 07319006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-15
[patent_title] => 'Serpentine transmembrane antigens expressed in human cancers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/856109
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 44
[patent_no_of_words] => 22154
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/319/07319006.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856109
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856109 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | May 27, 2004 | Issued |
Array
(
[id] => 7465994
[patent_doc_number] => 20040198653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/481066
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6239
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198653.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481066
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481066 | Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof | May 23, 2004 | Abandoned |
Array
(
[id] => 7295892
[patent_doc_number] => 20040214191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Human ras interacting protein'
[patent_app_type] => new
[patent_app_number] => 10/495446
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 36091
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214191.pdf
[firstpage_image] =>[orig_patent_app_number] => 10495446
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/495446 | Human ras interacting protein | May 11, 2004 | Abandoned |
Array
(
[id] => 5210380
[patent_doc_number] => 20070248964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Method and Device for Detection of Nucleic Acids and/or Polypetides'
[patent_app_type] => utility
[patent_app_number] => 11/568154
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9776
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20070248964.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568154
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568154 | Method and device for detection of nucleic acids and/or polypeptides | Apr 28, 2004 | Issued |
Array
(
[id] => 7427669
[patent_doc_number] => 20040209264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'New essential downstream component of the wingless signalling pathway'
[patent_app_type] => new
[patent_app_number] => 10/472385
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9691
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209264.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472385
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472385 | New essential downstream component of the wingless signalling pathway | Apr 26, 2004 | Abandoned |